Altimmune ALT Total debt

Total debt at other companies

Eli LillyLLY

$54.91B+37.6%

Merck & Co.MRK

$56.73B+54.0%

Madrigal Pharmaceuticals, Inc.MDGL

$377.85M+179%

VAN

Vivani MedicalVANI

$18.28M-3.5%

Viking TherapeuticsVKTX

$137K-87.8%

Wave Life SciencesWVE

$43.59M+101%

FAQ

What is Altimmune's total debt?

Altimmune (ALT) reported total debt of $34.77M in Q1 2026.

How has Altimmune's total debt changed year-over-year?

Altimmune's total debt increased by 14091.8% year-over-year, from $245K to $34.77M.

What is the long-term trend for Altimmune's total debt?

Over 5 years (2020 to 2025), Altimmune's total debt has grown at a 57.7% compound annual growth rate (CAGR), from $3.65M to $35.69M.

What does total debt mean?

Total debt represents the aggregate sum of all interest-bearing financial obligations, including short-term borrowings, the current portion of long-term debt, and long-term debt instruments. It also encompasses capitalized lease liabilities and other debt-like financing arrangements that require fixed repayment schedules. This metric serves as a comprehensive indicator of a company's total financial leverage and its reliance on external capital providers.